Ghazi Bahair, Deigni Olivier, Yezhelyev Maksym, Losken Albert
Division of Plastic and Reconstructive Surgery, Emory University School of Medicine, Atlanta, GA, USA.
Ann Plast Surg. 2011 May;66(5):488-92. doi: 10.1097/SAP.0b013e31820d18db.
The management of complex abdominal wall defects is challenging and often requires an individualized strategy with additional measures to minimize morbidity and recurrence. We retrospectively reviewed all patients who underwent reconstruction of complex abdominal wall defects at Emory Hospital by the senior author over a 7-year period. Abdominal hernia defects were categorized into primary, secondary, and tertiary hernias; infection; composite tumor defects; and dehiscence. Charts were queried for comorbidities, surgical technique, and outcome measures such as complications and recurrence. A total of 165 patients included in the series, with an average age of 52 years, and an average body mass index of 38 kg/m. Mesh was used in 81.8% of cases, 77% of those (mesh) being acellular dermal matrices (ADM). Component separation was performed in 75 patients (45.4%). The overall complication rate was 23.6% (39/165) including infection, delayed healing, skin necrosis, and fistulae, and was higher in patients with 2 or more comorbidities and those who required synthetic mesh reconstruction. The hernia recurrence or bulge was observed in 20.6% (34/165), and 29.4% of these patients required an additional, equally complex procedure. Hernia recurrence was significantly associated with a history of previous recurrent hernia, and hypertension (P < 0.04 and P = 0.001, respectively). Recurrence was higher in patients with 2 or more comorbidities (26% vs. 14%, P = 0.022). The recurrence rate was similar for synthetic and ADM reconstructions; however, the complication rates were higher when synthetic mesh was used. Attention to surgical technique, optimization of comorbidities, and the increased use of biologic meshes will minimize the need for operative intervention of complications following reconstruction of complex abdominal wall defects. Components separation and ADM have been very useful additions to the surgical management in these high-risk patients.
复杂腹壁缺损的处理具有挑战性,通常需要个体化策略及额外措施以将发病率和复发率降至最低。我们回顾性分析了资深作者在7年期间于埃默里医院接受复杂腹壁缺损重建的所有患者。腹疝缺损分为原发性、继发性和复发性疝;感染;复合肿瘤缺损;以及切口裂开。查询病历以了解合并症、手术技术以及诸如并发症和复发等结局指标。该系列共纳入165例患者,平均年龄52岁,平均体重指数为38kg/m²。81.8%的病例使用了补片,其中77%(补片)为脱细胞真皮基质(ADM)。75例患者(45.4%)进行了成分分离。总体并发症发生率为23.6%(39/165),包括感染、愈合延迟、皮肤坏死和瘘管,在有2种或更多合并症的患者以及需要合成补片重建的患者中发生率更高。20.6%(34/165)的患者出现疝复发或隆起,其中29.4%的患者需要再次进行同样复杂的手术。疝复发与既往复发性疝病史以及高血压显著相关(分别为P < 0.04和P = 0.001)。有2种或更多合并症的患者复发率更高(26%对14%,P = 0.022)。合成补片和ADM重建的复发率相似;然而,使用合成补片时并发症发生率更高。注重手术技术、优化合并症以及增加生物补片的使用将减少复杂腹壁缺损重建后并发症的手术干预需求。成分分离和ADM对这些高危患者的手术管理非常有用。